1Schmidt,AC.Antiviral therapy for influenza:a clinical and economic comparative review[J].Drugs,2004,64(18):2 031.
2Astrahan P,Kass I,Cooper MA,et al.A novel method of resistance for influenza against a chaneel-bloking antiviral drugs[J].Proteins,2004,55(2):251.
3Saito R,Sakai T,sato I,et al.Frequency of amantadine -resistant influenza A viruses during two seasons featuring cocirculation of H 1N 1 and H3N2[J].J Clin Microbiol,2003,41(5):2 164.
4De Jong JC,Beyer WE,Rimmelzwaan GF,et al.Neuraminidase inhibitors oseltamivir and zanamivir:new means of defence against influenza[J].Ned Tijdschr Geneeskd,2004,148(2):73.
5Boivin G,Goyette N.Susceptibility of recent canadian influenza A and B virus isolates to different nueraminidase inhibitor[J].Antiviral Res,2002,54:143.
6Sidwell RW,Smee DF.Peramivir (BCX-1812,RWJ -270201):potential new therapy for influenza[J].Expert Opin Investing Drugs,2002,11:859.
7Gary T Wang,Yuanwei Chen,Sheldon Wang,et al.Design,Synthesis and stractural analysis of influenza nueraminidase inhibitor containing pyrrolidine cores[J].Med Chem,2001,44:1 192.
8Kentaro Takeda,Yoichi Nakao,Shigeki Matsunaga,et al.A new nueraminidase inhibitor triterpenoidal saponin from the marine sponge erylus nobilis[J].Prod,2002,65:411.
9Lalezari J.Efficacy and safety of the nueraminidase inhibitor zanamivir in treatment human influenza with influenza A and B virus infection[J].Arch Intern Med,2001,161(2):212.
10Treanor JJ,Hayden FG,Vrooman PS,et al.Efficacy and safety of the oral nueraminidase inhibitor oseltamivir in treating acute influenza:a randomized controlled trial.US Oral Neuraminidase Study Group[J].JAMA,2000,283(8):1 016.
